De novo design of miniproteins targeting GPCRs

AI Summary

A new study provides insights into the de novo design of miniproteins that target G protein-coupled receptors (GPCRs), which are essential for drug discovery and development. This research could have significant implications for advancements in pharmaceuticals.

G protein-coupled receptors (GPCRs) play key roles in physiology and are central targets for drug discovery and development1,2, ...